Matrix metalloproteinase expression in human retinal microvascular cells

Maria B. Grant, Sergio Caballero, Roy W. Tarnuzzer, Kathryn E. Bass, Alexander V. Ljubimov, Polyxenie E. Spoerri, Richard E. Galardy

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The degree of hyperglycemia correlates with the development of diabetic retinopathy. We investigated the effect of glucose on the expression of matrix metalloproteinase (MMP)-2 and MMP-9 (72-kDa and 92-kDa type IV collagenases, respectively) by human retinal microvascular endothelial cells (HRECs). Cultured HRECs from nondiabetic and diabetic donors were exposed to 5 or 30 mmol/l glucose. Using gelatin zymography, conditioned medium (CM) from all cultures revealed a gelatinolytic band migrating at 65 kDa (representing the proform of MMP-2 that runs at 72 kDa under reducing conditions). This band was unchanged by glucose exposure or the disease state of the donors. CM from nondiabetic HREC cultures demonstrated an additional proteolytic activity migrating at 90 kDa when cells were exposed to 30 mmol/l glucose, but not when they were exposed to 5 mmol/l glucose. This same activity was seen in CM from HREC cultures of diabetic origin in the presence of both 5 and 30 mmol/l glucose. Western analysis confirmed the identity of the 65-kDa band as MMP-2. The anomalous activity at 90 kDa was identified as MMP-2 associated and co-migrating with a fibronectin fragment. Competition- based reverse transcription-polymerase chain reaction revealed that nondiabetic and diabetic HRECs expressed constitutively mRNA for MMP-2, MMP- 9, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, and fibronectin. After exposure to 5 or 30 mmol/l glucose, no changes were detected in mRNA levels in MMP-2 or MMP-9, their inhibitors TIMP-1 and TIMP-2, or fibronectin in either nondiabetic or diabetic HREC cultures. These results support the notion that modulation of MMP function by extracellular matrix components occurs in response to glucose and may be relevant to the development of diabetic retinopathy.

Original languageEnglish (US)
Pages (from-to)1311-1317
Number of pages7
JournalDiabetes
Volume47
Issue number8
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Matrix Metalloproteinases
Matrix Metalloproteinase 2
Glucose
Endothelial Cells
Matrix Metalloproteinase 9
Conditioned Culture Medium
Fibronectins
Tissue Inhibitor of Metalloproteinase-2
Tissue Inhibitor of Metalloproteinase-1
Cell Culture Techniques
Diabetic Retinopathy
Messenger RNA
Gelatin
Hyperglycemia
Reverse Transcription
Extracellular Matrix
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Grant, M. B., Caballero, S., Tarnuzzer, R. W., Bass, K. E., Ljubimov, A. V., Spoerri, P. E., & Galardy, R. E. (1998). Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes, 47(8), 1311-1317. https://doi.org/10.2337/diabetes.47.8.1311

Matrix metalloproteinase expression in human retinal microvascular cells. / Grant, Maria B.; Caballero, Sergio; Tarnuzzer, Roy W.; Bass, Kathryn E.; Ljubimov, Alexander V.; Spoerri, Polyxenie E.; Galardy, Richard E.

In: Diabetes, Vol. 47, No. 8, 1998, p. 1311-1317.

Research output: Contribution to journalArticle

Grant, MB, Caballero, S, Tarnuzzer, RW, Bass, KE, Ljubimov, AV, Spoerri, PE & Galardy, RE 1998, 'Matrix metalloproteinase expression in human retinal microvascular cells', Diabetes, vol. 47, no. 8, pp. 1311-1317. https://doi.org/10.2337/diabetes.47.8.1311
Grant MB, Caballero S, Tarnuzzer RW, Bass KE, Ljubimov AV, Spoerri PE et al. Matrix metalloproteinase expression in human retinal microvascular cells. Diabetes. 1998;47(8):1311-1317. https://doi.org/10.2337/diabetes.47.8.1311
Grant, Maria B. ; Caballero, Sergio ; Tarnuzzer, Roy W. ; Bass, Kathryn E. ; Ljubimov, Alexander V. ; Spoerri, Polyxenie E. ; Galardy, Richard E. / Matrix metalloproteinase expression in human retinal microvascular cells. In: Diabetes. 1998 ; Vol. 47, No. 8. pp. 1311-1317.
@article{9476cc22181640ee9196bd4ef7c461aa,
title = "Matrix metalloproteinase expression in human retinal microvascular cells",
abstract = "The degree of hyperglycemia correlates with the development of diabetic retinopathy. We investigated the effect of glucose on the expression of matrix metalloproteinase (MMP)-2 and MMP-9 (72-kDa and 92-kDa type IV collagenases, respectively) by human retinal microvascular endothelial cells (HRECs). Cultured HRECs from nondiabetic and diabetic donors were exposed to 5 or 30 mmol/l glucose. Using gelatin zymography, conditioned medium (CM) from all cultures revealed a gelatinolytic band migrating at 65 kDa (representing the proform of MMP-2 that runs at 72 kDa under reducing conditions). This band was unchanged by glucose exposure or the disease state of the donors. CM from nondiabetic HREC cultures demonstrated an additional proteolytic activity migrating at 90 kDa when cells were exposed to 30 mmol/l glucose, but not when they were exposed to 5 mmol/l glucose. This same activity was seen in CM from HREC cultures of diabetic origin in the presence of both 5 and 30 mmol/l glucose. Western analysis confirmed the identity of the 65-kDa band as MMP-2. The anomalous activity at 90 kDa was identified as MMP-2 associated and co-migrating with a fibronectin fragment. Competition- based reverse transcription-polymerase chain reaction revealed that nondiabetic and diabetic HRECs expressed constitutively mRNA for MMP-2, MMP- 9, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, and fibronectin. After exposure to 5 or 30 mmol/l glucose, no changes were detected in mRNA levels in MMP-2 or MMP-9, their inhibitors TIMP-1 and TIMP-2, or fibronectin in either nondiabetic or diabetic HREC cultures. These results support the notion that modulation of MMP function by extracellular matrix components occurs in response to glucose and may be relevant to the development of diabetic retinopathy.",
author = "Grant, {Maria B.} and Sergio Caballero and Tarnuzzer, {Roy W.} and Bass, {Kathryn E.} and Ljubimov, {Alexander V.} and Spoerri, {Polyxenie E.} and Galardy, {Richard E.}",
year = "1998",
doi = "10.2337/diabetes.47.8.1311",
language = "English (US)",
volume = "47",
pages = "1311--1317",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - Matrix metalloproteinase expression in human retinal microvascular cells

AU - Grant, Maria B.

AU - Caballero, Sergio

AU - Tarnuzzer, Roy W.

AU - Bass, Kathryn E.

AU - Ljubimov, Alexander V.

AU - Spoerri, Polyxenie E.

AU - Galardy, Richard E.

PY - 1998

Y1 - 1998

N2 - The degree of hyperglycemia correlates with the development of diabetic retinopathy. We investigated the effect of glucose on the expression of matrix metalloproteinase (MMP)-2 and MMP-9 (72-kDa and 92-kDa type IV collagenases, respectively) by human retinal microvascular endothelial cells (HRECs). Cultured HRECs from nondiabetic and diabetic donors were exposed to 5 or 30 mmol/l glucose. Using gelatin zymography, conditioned medium (CM) from all cultures revealed a gelatinolytic band migrating at 65 kDa (representing the proform of MMP-2 that runs at 72 kDa under reducing conditions). This band was unchanged by glucose exposure or the disease state of the donors. CM from nondiabetic HREC cultures demonstrated an additional proteolytic activity migrating at 90 kDa when cells were exposed to 30 mmol/l glucose, but not when they were exposed to 5 mmol/l glucose. This same activity was seen in CM from HREC cultures of diabetic origin in the presence of both 5 and 30 mmol/l glucose. Western analysis confirmed the identity of the 65-kDa band as MMP-2. The anomalous activity at 90 kDa was identified as MMP-2 associated and co-migrating with a fibronectin fragment. Competition- based reverse transcription-polymerase chain reaction revealed that nondiabetic and diabetic HRECs expressed constitutively mRNA for MMP-2, MMP- 9, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, and fibronectin. After exposure to 5 or 30 mmol/l glucose, no changes were detected in mRNA levels in MMP-2 or MMP-9, their inhibitors TIMP-1 and TIMP-2, or fibronectin in either nondiabetic or diabetic HREC cultures. These results support the notion that modulation of MMP function by extracellular matrix components occurs in response to glucose and may be relevant to the development of diabetic retinopathy.

AB - The degree of hyperglycemia correlates with the development of diabetic retinopathy. We investigated the effect of glucose on the expression of matrix metalloproteinase (MMP)-2 and MMP-9 (72-kDa and 92-kDa type IV collagenases, respectively) by human retinal microvascular endothelial cells (HRECs). Cultured HRECs from nondiabetic and diabetic donors were exposed to 5 or 30 mmol/l glucose. Using gelatin zymography, conditioned medium (CM) from all cultures revealed a gelatinolytic band migrating at 65 kDa (representing the proform of MMP-2 that runs at 72 kDa under reducing conditions). This band was unchanged by glucose exposure or the disease state of the donors. CM from nondiabetic HREC cultures demonstrated an additional proteolytic activity migrating at 90 kDa when cells were exposed to 30 mmol/l glucose, but not when they were exposed to 5 mmol/l glucose. This same activity was seen in CM from HREC cultures of diabetic origin in the presence of both 5 and 30 mmol/l glucose. Western analysis confirmed the identity of the 65-kDa band as MMP-2. The anomalous activity at 90 kDa was identified as MMP-2 associated and co-migrating with a fibronectin fragment. Competition- based reverse transcription-polymerase chain reaction revealed that nondiabetic and diabetic HRECs expressed constitutively mRNA for MMP-2, MMP- 9, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, and fibronectin. After exposure to 5 or 30 mmol/l glucose, no changes were detected in mRNA levels in MMP-2 or MMP-9, their inhibitors TIMP-1 and TIMP-2, or fibronectin in either nondiabetic or diabetic HREC cultures. These results support the notion that modulation of MMP function by extracellular matrix components occurs in response to glucose and may be relevant to the development of diabetic retinopathy.

UR - http://www.scopus.com/inward/record.url?scp=0031870301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031870301&partnerID=8YFLogxK

U2 - 10.2337/diabetes.47.8.1311

DO - 10.2337/diabetes.47.8.1311

M3 - Article

C2 - 9703333

AN - SCOPUS:0031870301

VL - 47

SP - 1311

EP - 1317

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -